Posted in | News | Photonics | Electronics

Lightwave Logic Acquires Rights to Corning's Organic Electro-Optical Materials

Lightwave Logic, Inc. has entered into a sole worldwide license agreement with Corning Incorporated enabling Lightwave to integrate Corning's organic electro-optical chromophores into Lightwave Logic's portfolio of electro-optic polymer materials.

The agreement allows Lightwave to use the licensed patents within a defined license field that includes communications, computing, power, and power storage applications utilizing the nonlinear optical properties of their materials. Lightwave Logic is a technology company focused on the development of Next Generation Photonic Devices and Non-Linear Optical Polymer Materials Systems for applications in high-speed fiber-optic data communications and optical computing.

Tom Zelibor, chairman and CEO of Lightwave Logic commented, "We are extremely pleased to acquire rights to Corning's organic electro-optical materials. Together with the recent advancements we have made developing our new multi-chromophore synthesis process, the addition of these materials will significantly expand the number of potential chromophore combinations to drive the continuous improvement of powerful nonlinear organic electro-optical materials. These materials will be used in state of the art photonic devices to fulfill today's needs and the future demands of data centers and telecommunications networks for many years to come."

Powered by Lightwave Logic
Lightwave Logic, Inc. is a development stage company that produces prototype electro-optic demonstration devices and is moving toward commercialization of its high-activity, high-stability organic polymers for applications in electro-optical device markets. Electro-optical devices convert data from electric signals into optical signals for use in high-speed fiber-optic telecommunications systems and optical computers. For more information, about the Company please visit the corporate website at: www.lightwavelogic.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.